Therefore, a PSA cutoff level of 7 ng/mL seemed reasonable for exploring the predispositions of risk SNPs for prostate cancer, reducing treatment-related complications, and reducing public health burdens. This evidence concerns the gene KLK3 and prostate carcinoma.